Fraudulent (and non fraudulent) fatty acids for human health

European Journal of Clinical Investigation

Volumn 23, Issue 11, 1993, Pages 686-689

  SIRTORI, C R ^a   GALLI, C ^a   FRANCESCHINI, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SATURATED FATTY ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

DIET; HUMAN; LIPID METABOLISM; PRIORITY JOURNAL; REVIEW;

FATTY ACIDS; HUMAN; LIPIDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0027495156     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1993.tb01286.x     Document Type: Editorial

References (42)

1. Dietary influences on serum lipids and lipoproteins
2. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia
3. Mechanisms by which saturated triacylglycerols elevate the plasma low density lipopro‐tein‐cholesterol concentration in hamsters. Differential effects of fatty acids chain length
4. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man
5. Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high‐risk patients.
6. Olive oil, corii oil, and n‐3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemia.
7. Effects of fibrates on serum lipids and atherosclerosis
8. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
9. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver
10. (Coordinator) Peroxisomes: Biochemistry, molecular biology and genetic diseases
11. Determinants of target gene specificity for steroid/thyroid hormone receptors
12. Fatty acids activate a chimera of the clofibric acid‐activated receptor and the glucocorticoid receptor
13. Control of the peroxisomal β‐oxidation pathway by a novel family of nuclear hormone receptors.
14. Bar‐Tana J. Prevention of peroxisomal proliferation by carnitine palmitoyltransferase inhibitors in cultured rat hepato‐cytes and in vivo:
15. Hypolipidaemic drugs are activated to acyl‐CoA esters in isolated rat hepatocytes.
16. 1‐tetra‐substituted long chain dioic acids.
17. Alkylthioacetic acid (3‐thia fatty acids)—a new group of non‐p‐oxidizable, peroxisome‐inducing fatty acid analogues. I. A study on the structural requirements for proliferation of peroxisomes and mitochondria in rat liver
18. Dietary regulation of fatty acid and triglyceride metabolism
19. 2‐like particles during lipolysis of very low density lipoproteins in vitro
20. Bezafibrate lowers plasma lipids, fibronogen and platelet aggregability in hypertriglyceridemia.
21. Tolerability of fibric acids. Comparative data and biochemical bases
22. Effects of gemfibrozil on lipids and haemostasis after myocardial infarction
23. Characterization of the hepatic responses to the short‐term administration of ciprofibrate in several rat strains. Co‐induction of microsomal cytochrome P‐450 IVAAI and peroxisome proliferation
24. Sex‐dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid ω‐hydroxylases
25. 2α
26. Stereochemical selectivity in the induction of cytochrome P450IVAI (P452)‐dependent fatty acid hydroxy‐lation and peroxisome proliferation
27. The peroxisome prolifer‐ator‐activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acids ω‐hydroxylase, by clofibric acid
28. The cytochrome P‐450 and lipid/lipoprotein metabolism
29. Relationship between morphological changes and lipid‐lowering action of p‐chlorphe‐noxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man
30. Morphonetic study of human hepatic cell modifications induced by fenofibrate.
31. Peroxisomal disorders
32. Dietary erucic acid therapy for X‐linked adrenoleukodystrophy.
33. Mechanism of action of clofibrate
34. Reduced triglyceride formation from long‐chain polyenoic fatty acids in rat hepatocytes
35. Serum lipids, hepatic glycerolipid metabolism and peroxisomal fatty acid oxidation in rats fed ω‐3 and ω‐6 fatty acids
36. Involvement of calmodulin‐ and protein kinase C‐related mechanism in an induction process of peroxisomal fatty acid oxidation‐related enzymes by hypolipidemic peroxisome proliferators
37. A new mechanism of transcriptional regulation. Release of an activator triggered by small molecule binding
38. Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver
39. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene
40. Hypolipidaemic hepatic peroxisome profifemtors form a novel class of chemical carcinogens
41. Convergence of 9‐cis retinoic acid and peroxisome proliferation signalling pathways through heterodimer formation of their receptors.
42. Induction of peroxisomal fatty acid β‐oxidation and liver fatty acid‐binding protein by peroxisome proliferates.